10-K Filing

Xenetic Biosciences, Inc. CIK: 1534525 FY 2024

Filing Information

Form Type	10-K
Accession Number	`0001683168-25-001686`
Period End Date	20241231
Filing Date	20250318
Fiscal Year	2024
Fiscal Period	FY
XBRL Instance	xenetic_i10k-123124_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 90 Income Statement 56 Cash Flow Statement 56 Stockholders Equity 28

Balance Sheet 90 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$6.17M	USD	Point-in-time
Cash	`Cash`	$6.17M	USD	Point-in-time
Cash	`Cash`	$8.98M	USD	Point-in-time
Cash	`Cash`	$8.98M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$421.95K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$421.95K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$603.83K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$603.83K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.59M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.59M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.59M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.59M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	10.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	10.00M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$313.92K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$313.92K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.02M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.02M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	10.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	10.00M	shares	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	1.54M	shares	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	1.54M	shares	Point-in-time
Total assets	`Assets`	$6.90M	USD	Point-in-time
Total assets	`Assets`	$6.90M	USD	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	1.54M	shares	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	1.54M	shares	Point-in-time
Total assets	`Assets`	$10.61M	USD	Point-in-time
Total assets	`Assets`	$10.61M	USD	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	1.54M	shares	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	1.54M	shares	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	1.54M	shares	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	1.54M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$283.62K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$283.62K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$240.83K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$240.83K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$610.65K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$610.65K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$568.75K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$568.75K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$809.59K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$809.59K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$894.26K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$894.26K	USD	Point-in-time
Total liabilities	`Liabilities`	$894.26K	USD	Point-in-time
Total liabilities	`Liabilities`	$894.26K	USD	Point-in-time
Total liabilities	`Liabilities`	$809.59K	USD	Point-in-time
Total liabilities	`Liabilities`	$809.59K	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 10,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 1,544,840 and 1,543,385 shares issued as of December 31, 2024 and December 31, 2023, respectively; 1,542,139 and 1,540,684 shares outstanding as of December 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$1.54K	USD	Point-in-time
Common stock, $0.001 par value; 10,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 1,544,840 and 1,543,385 shares issued as of December 31, 2024 and December 31, 2023, respectively; 1,542,139 and 1,540,684 shares outstanding as of December 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$1.54K	USD	Point-in-time
Common stock, $0.001 par value; 10,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 1,544,840 and 1,543,385 shares issued as of December 31, 2024 and December 31, 2023, respectively; 1,542,139 and 1,540,684 shares outstanding as of December 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$1.54K	USD	Point-in-time
Common stock, $0.001 par value; 10,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 1,544,840 and 1,543,385 shares issued as of December 31, 2024 and December 31, 2023, respectively; 1,542,139 and 1,540,684 shares outstanding as of December 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$1.54K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$208.05M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$208.05M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$208.23M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$208.23M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-197.19M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-197.19M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-193.23M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-193.23M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockCommonValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockCommonValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockCommonValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockCommonValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.01M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.01M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$13.65M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$13.65M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.80M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.80M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$10.61M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$10.61M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.90M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.90M	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Royalty revenue	`RoyaltyIncomeNonoperating`	$2.50M	USD	Annual
Royalty revenue	`RoyaltyIncomeNonoperating`	$2.50M	USD	Annual
Royalty revenue	`RoyaltyIncomeNonoperating`	$2.54M	USD	Annual
Royalty revenue	`RoyaltyIncomeNonoperating`	$2.54M	USD	Annual
Total revenue	`Revenues`	$2.50M	USD	Annual
Total revenue	`Revenues`	$2.50M	USD	Annual
Total revenue	`Revenues`	$2.54M	USD	Annual
Total revenue	`Revenues`	$2.54M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.29M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.29M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.49M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.49M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$3.42M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$3.42M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$3.56M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$3.56M	USD	Annual
Total operating costs and expenses	`OperatingExpenses`	$7.06M	USD	Annual
Total operating costs and expenses	`OperatingExpenses`	$7.06M	USD	Annual
Total operating costs and expenses	`OperatingExpenses`	$6.70M	USD	Annual
Total operating costs and expenses	`OperatingExpenses`	$6.70M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-4.20M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-4.20M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-4.52M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-4.52M	USD	Annual
Other (expense) income	`OtherNonoperatingIncomeExpense`	$-5.71K	USD	Annual
Other (expense) income	`OtherNonoperatingIncomeExpense`	$-5.71K	USD	Annual
Other (expense) income	`OtherNonoperatingIncomeExpense`	$25.38K	USD	Annual
Other (expense) income	`OtherNonoperatingIncomeExpense`	$25.38K	USD	Annual
Interest income, net	`InterestIncomeExpenseNet`	$249.86K	USD	Annual
Interest income, net	`InterestIncomeExpenseNet`	$249.86K	USD	Annual
Interest income, net	`InterestIncomeExpenseNet`	$355.76K	USD	Annual
Interest income, net	`InterestIncomeExpenseNet`	$355.76K	USD	Annual
Total other income, net	`NonoperatingIncomeExpense`	$244.15K	USD	Annual
Total other income, net	`NonoperatingIncomeExpense`	$244.15K	USD	Annual
Total other income, net	`NonoperatingIncomeExpense`	$381.14K	USD	Annual
Total other income, net	`NonoperatingIncomeExpense`	$381.14K	USD	Annual
Net loss	`NetIncomeLoss`	$-4.13M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.13M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.96M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.96M	USD	Annual
Basic net loss per share	`EarningsPerShareBasic`	$-2.57	USD	Annual
Basic net loss per share	`EarningsPerShareBasic`	$-2.57	USD	Annual
Basic net loss per share	`EarningsPerShareBasic`	$-2.71	USD	Annual
Basic net loss per share	`EarningsPerShareBasic`	$-2.71	USD	Annual
Diluted net loss per share	`EarningsPerShareDiluted`	$-2.71	USD	Annual
Diluted net loss per share	`EarningsPerShareDiluted`	$-2.71	USD	Annual
Diluted net loss per share	`EarningsPerShareDiluted`	$-2.57	USD	Annual
Diluted net loss per share	`EarningsPerShareDiluted`	$-2.57	USD	Annual
Weighted-average shares of common stock outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.53M	shares	Annual
Weighted-average shares of common stock outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.53M	shares	Annual
Weighted-average shares of common stock outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.54M	shares	Annual
Weighted-average shares of common stock outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.54M	shares	Annual
Weighted-average shares of common stock outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.53M	shares	Annual
Weighted-average shares of common stock outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.53M	shares	Annual
Weighted-average shares of common stock outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.54M	shares	Annual
Weighted-average shares of common stock outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.54M	shares	Annual

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-4.13M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.13M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.96M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.96M	USD	Annual
Share-based expense	`EmployeeBenefitsAndShareBasedCompensation`	$283.08K	USD	Annual
Share-based expense	`EmployeeBenefitsAndShareBasedCompensation`	$283.08K	USD	Annual
Share-based expense	`EmployeeBenefitsAndShareBasedCompensation`	$171.81K	USD	Annual
Share-based expense	`EmployeeBenefitsAndShareBasedCompensation`	$171.81K	USD	Annual
Prepaid expenses and other	`IncreaseDecreaseInAccountsAndOtherReceivables`	$47.73K	USD	Annual
Prepaid expenses and other	`IncreaseDecreaseInAccountsAndOtherReceivables`	$47.73K	USD	Annual
Prepaid expenses and other	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-181.87K	USD	Annual
Prepaid expenses and other	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-181.87K	USD	Annual
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-48.58K	USD	Annual
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-48.58K	USD	Annual
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-704.43K	USD	Annual
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-704.43K	USD	Annual
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-263.57K	USD	Annual
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-263.57K	USD	Annual
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$84.68K	USD	Annual
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$84.68K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.11M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.11M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.82M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.82M	USD	Annual
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-2.82M	USD	Annual
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-2.82M	USD	Annual
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-4.11M	USD	Annual
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-4.11M	USD	Annual
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.17M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.17M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.98M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.98M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.10M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.10M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.17M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.17M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.98M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.98M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.10M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.10M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	Annual
Cash paid for interest	`InterestPaidNet`	-	USD	Annual
Cash paid for interest	`InterestPaidNet`	-	USD	Annual
Cash paid for interest	`InterestPaidNet`	-	USD	Annual
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$1.00	USD	Annual
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$1.00	USD	Annual
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	-	USD	Annual
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	-	USD	Annual
Issuance of common stock to adjust for Reverse Stock Split	`IssuanceOfCommonStockToAdjustForReverseStockSplit`	$16.00	USD	Annual
Issuance of common stock to adjust for Reverse Stock Split	`IssuanceOfCommonStockToAdjustForReverseStockSplit`	$16.00	USD	Annual
Issuance of common stock to adjust for Reverse Stock Split	`IssuanceOfCommonStockToAdjustForReverseStockSplit`	-	USD	Annual
Issuance of common stock to adjust for Reverse Stock Split	`IssuanceOfCommonStockToAdjustForReverseStockSplit`	-	USD	Annual
Conversion of Series A preferred stock to common stock	`ConversionOfSeriesPreferredStockToCommonStock`	$970.00	USD	Annual
Conversion of Series A preferred stock to common stock	`ConversionOfSeriesPreferredStockToCommonStock`	$970.00	USD	Annual
Conversion of Series A preferred stock to common stock	`ConversionOfSeriesPreferredStockToCommonStock`	-	USD	Annual
Conversion of Series A preferred stock to common stock	`ConversionOfSeriesPreferredStockToCommonStock`	-	USD	Annual

Stockholders Equity 28 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$6.01M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$6.01M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$13.65M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$13.65M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$9.80M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$9.80M	USD	Point-in-time
Issuance of common stock in connection with restricted stock units	`IssuanceOfCommonStockInConnectionWithRestrictedStockUnits`	-	USD	Annual
Issuance of common stock in connection with restricted stock units	`IssuanceOfCommonStockInConnectionWithRestrictedStockUnits`	-	USD	Annual
Exercise of purchase warrants	`ExerciseOfPurchaseWarrants`	-	USD	Annual
Exercise of purchase warrants	`ExerciseOfPurchaseWarrants`	-	USD	Annual
Issuance of common stock to adjust for reverse split rounding	`IssuanceOfCommonStockToAdjustForReverseSplitRounding`	-	USD	Annual
Issuance of common stock to adjust for reverse split rounding	`IssuanceOfCommonStockToAdjustForReverseSplitRounding`	-	USD	Annual
Conversion of Series A preferred stock to shares of common stock	`ConversionOfSeriesPreferredStockToSharesOfCommonStock`	-	USD	Annual
Conversion of Series A preferred stock to shares of common stock	`ConversionOfSeriesPreferredStockToSharesOfCommonStock`	-	USD	Annual
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$283.08K	USD	Annual
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$283.08K	USD	Annual
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$171.81K	USD	Annual
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$171.81K	USD	Annual
Net loss	`NetIncomeLoss`	$-4.13M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.13M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.96M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.96M	USD	Annual
Ending balance, value	`StockholdersEquity`	$6.01M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$6.01M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$13.65M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$13.65M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$9.80M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$9.80M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.